1 Pulmonary Branch, Laboratory of Translational Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Building 10, Room 6D05, 9000 Rockville Pike, Bethesda, MD 20892-1590, USA.
Novel drug targets are identified in lymphangioleiomyomatosis (LAM), a rare disease in women. These targets focus on uterine transcription factors necessary for LAM cell survival.